These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 27940933

  • 1. Management of functional Sprint Fidelis leads at cardiac resynchronization therapy-defibrillator generator replacement: a novel option for preventing inappropriate shocks from lead failure in fragile patients with high risk of sudden death.
    Zhu DWX, Chu MM, House CM.
    Europace; 2017 Dec 01; 19(12):2007-2014. PubMed ID: 27940933
    [Abstract] [Full Text] [Related]

  • 2. Left ventricular dimensions predict risk of appropriate shocks but not mortality in cardiac resynchronization therapy-defibrillator recipients with left bundle-branch block and non-ischemic cardiomyopathy.
    Adelstein EC, Schwartzman D, Jain S, Bazaz R, Wang NC, Saba S.
    Europace; 2017 Oct 01; 19(10):1689-1694. PubMed ID: 27856539
    [Abstract] [Full Text] [Related]

  • 3. Management of recalled implantable cardioverter-defibrillator leads at generator replacement: a decision analysis model for Fidelis leads.
    Burri H, Combescure C.
    Europace; 2014 Aug 01; 16(8):1210-7. PubMed ID: 24469434
    [Abstract] [Full Text] [Related]

  • 4. Reduction of inappropriate anti-tachycardia pacing therapies and shocks by a novel suite of detection algorithms in heart failure patients with cardiac resynchronization therapy defibrillators: a historical comparison of a prospective database.
    Lunati M, Proclemer A, Boriani G, Landolina M, Locati E, Rordorf R, Daleffe E, Ricci RP, Catanzariti D, Tomasi L, Gulizia M, Baccillieri MS, Molon G, Gasparini M, ClinicalService Cardiological Centres.
    Europace; 2016 Sep 01; 18(9):1391-8. PubMed ID: 26826135
    [Abstract] [Full Text] [Related]

  • 5. Atrial fibrillation in cardiac resynchronization therapy with a defibrillator: a risk factor for mortality, appropriate and inappropriate shocks.
    van Boven N, Theuns D, Bogaard K, Ruiter J, Kimman G, Berman L, VAN DER Ploeg T, Kardys I, Umans V.
    J Cardiovasc Electrophysiol; 2013 Oct 01; 24(10):1116-22. PubMed ID: 23889733
    [Abstract] [Full Text] [Related]

  • 6. Patients upgraded to cardiac resynchronization therapy due to pacing-induced cardiomyopathy are at low risk of life-threatening ventricular arrhythmias: a long-term cause-of-death analysis.
    Barra S, Duehmke R, Providencia R, Marijon E, Boveda S, Virdee M, Heck P, Fynn S, Begley D, Grace A, Agarwal S.
    Europace; 2018 Jan 01; 20(1):89-96. PubMed ID: 28031276
    [Abstract] [Full Text] [Related]

  • 7. Increase of ventricular interval during atrial fibrillation by atrioventricular node vagal stimulation: chronic clinical atrioventricular-nodal stimulation download study.
    Bianchi S, Rossi P, Schauerte P, Elvan A, Blomström-Lundqvist C, Kornet L, Gal P, Mörtsell D, Wouters G, Gemein C.
    Circ Arrhythm Electrophysiol; 2015 Jun 01; 8(3):562-8. PubMed ID: 25878323
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Multipolar pacing by cardiac resynchronization therapy with a defibrillators treatment in type 2 diabetes mellitus failing heart patients: impact on responders rate, and clinical outcomes.
    Sardu C, Barbieri M, Santamaria M, Giordano V, Sacra C, Paolisso P, Spirito A, Marfella R, Paolisso G, Rizzo MR.
    Cardiovasc Diabetol; 2017 Jun 09; 16(1):75. PubMed ID: 28599667
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Small-Caliber Lead Failure After Generator Exchange.
    Salgado R, Martín J, Martínez J, Alzueta J, Viñolas X, Fernández J, Molina M, Pérez L, Calvo D, García J.
    J Cardiovasc Electrophysiol; 2016 Jul 09; 27(7):846-50. PubMed ID: 27090984
    [Abstract] [Full Text] [Related]

  • 12. The Occurrence of Implantable Cardioverter Defibrillator Therapies After Generator Replacement in Patients Who No Longer Meet Primary Prevention Indications.
    Kawata H, Hirai T, Doukas D, Hirai R, Steinbrunner J, Wilson J, Noda T, Hsu J, Krummen D, Feld G, Wilber D, Santucci P, Birgersdotter-Green U.
    J Cardiovasc Electrophysiol; 2016 Jun 09; 27(6):724-9. PubMed ID: 26915696
    [Abstract] [Full Text] [Related]

  • 13. Clinical outcomes in cardiac resynchronization therapy-defibrillator recipients 80 years of age and older.
    Adelstein EC, Liu J, Jain S, Schwartzman D, Althouse AD, Wang NC, Gorcsan J, Saba S.
    Europace; 2016 Mar 09; 18(3):420-7. PubMed ID: 26487669
    [Abstract] [Full Text] [Related]

  • 14. Eligibility of Pacemaker Patients for Subcutaneous Implantable Cardioverter Defibrillators.
    Ip JE, Wu MS, Kennel PJ, Thomas G, Liu CF, Cheung JW, Markowitz SM, Lerman BB.
    J Cardiovasc Electrophysiol; 2017 May 09; 28(5):544-548. PubMed ID: 28185354
    [Abstract] [Full Text] [Related]

  • 15. Incremental benefit of cardiac resynchronisation therapy with versus without a defibrillator.
    Martens P, Verbrugge FH, Nijst P, Dupont M, Nuyens D, Herendael HV, Rivero-Ayerza M, Tang WH, Mullens W.
    Heart; 2017 Dec 09; 103(24):1977-1984. PubMed ID: 28716973
    [Abstract] [Full Text] [Related]

  • 16. Risk factors and the effect of cardiac resynchronization therapy on cardiac and non-cardiac mortality in MADIT-CRT.
    Perkiomaki JS, Ruwald AC, Kutyifa V, Ruwald MH, Mcnitt S, Polonsky B, Goldstein RE, Haigney MC, Krone RJ, Zareba W, Moss AJ, MADIT-CRT Investigators.
    Europace; 2015 Dec 09; 17(12):1816-22. PubMed ID: 26071234
    [Abstract] [Full Text] [Related]

  • 17. Primary Prevention Implantable Cardioverter Defibrillator (ICD) Therapy in Women-Data From a Multicenter French Registry.
    Providência R, Marijon E, Lambiase PD, Bouzeman A, Defaye P, Klug D, Amet D, Perier MC, Gras D, Algalarrondo V, Deharo JC, Leclercq C, Fauchier L, Babuty D, Bordachar P, Sadoul N, Piot O, Boveda S.
    J Am Heart Assoc; 2016 Feb 12; 5(2):. PubMed ID: 26873687
    [Abstract] [Full Text] [Related]

  • 18. A single-centre experience concerning the safety of Sprint Fidelis defibrillator lead extraction at the time of pulse generator replacement or in case of evidence of lead failure.
    Da Costa A, Da Cruz C, Romeyer-Bouchard C, Abdellaoui L, Nadrouss A, Bisch L, Chometon F, Afif Z, Gate-Martinet A, Combier M, Isaaz K.
    Arch Cardiovasc Dis; 2012 Apr 12; 105(4):203-10. PubMed ID: 22633294
    [Abstract] [Full Text] [Related]

  • 19. Complications of permanent cardiac pacing in patients with persistent left superior vena cava.
    Polewczyk A, Kutarski A, Czekajska-Chehab E, Adamczyk P, Boczar K, Polewczyk M, Janion M.
    Cardiol J; 2014 Apr 12; 21(2):128-37. PubMed ID: 24526508
    [Abstract] [Full Text] [Related]

  • 20. Rate, causes, and impact on patient outcome of implantable device complications requiring surgical revision: large population survey from two centres in Italy.
    Palmisano P, Accogli M, Zaccaria M, Luzzi G, Nacci F, Anaclerio M, Favale S.
    Europace; 2013 Apr 12; 15(4):531-40. PubMed ID: 23407627
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.